Namibia vs Tonga: Reported paralytic polio cases per million
Namibia
0 cases per million
in 2023
Tonga
0 cases per million
in 2000
Namibia rank
26th
Tonga rank
26th
Reported paralytic polio cases per million over time
- Namibia
- Tonga
How they compare
Namibia currently reports 0 cases per million against 0 cases per million in Tonga, a difference of 0 cases per million.
The two have swapped places 3 times across 12 shared years of data; in 1989 it was Namibia ahead.
Namibia ranks 26th and Tonga ranks 26th of 199 countries.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Namibia | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 0.7764 cases per million | 0 cases per million | 0.7764 cases per million | Namibia |
| 1990s | 5.59 cases per million | 0 cases per million | 5.59 cases per million | Namibia |
| 2000s | 0 cases per million | 0 cases per million | 0 cases per million | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported paralytic polio cases per million, Namibia or Tonga?
- Namibia, at 0 cases per million against 0 cases per million in Tonga as of 2023.
- What is the difference in reported paralytic polio cases per million between Namibia and Tonga?
- 0 cases per million, with Namibia ahead.
- How many years of comparable data are there for Namibia and Tonga?
- 12 years are reported by both, from 1989 to 2000.
- How do Namibia and Tonga rank globally for reported paralytic polio cases per million?
- Namibia ranks 26th and Tonga ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024); Population based on various sources (2023) – with major processing by Our World in Data, published as Reported paralytic polio cases per million. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The sum of wild poliovirus cases and circulating vaccine derived poliovirus cases per million people.